Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04741776
Other study ID # D21065
Secondary ID 1R34MH124951
Status Completed
Phase N/A
First received
Last updated
Start date April 22, 2021
Est. completion date November 14, 2023

Study information

Verified date December 2023
Source Dartmouth-Hitchcock Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Depressed mothers (pregnant and post-delivery) make up a significant portion of Maternal, Infant, and Early Childhood Home Visiting (MIECHV) clients. Home visited mothers often experience family conflict that precipitates or worsens their depressive symptoms. This study uses an effectiveness-implementation hybrid type 1 design with a pilot randomized trial to test the feasibility, acceptability, tolerability, safety, and preliminary effectiveness of an innovative family therapy intervention that uses technology to bypass barriers to increase access to treatment for this vulnerable population.


Recruitment information / eligibility

Status Completed
Enrollment 166
Est. completion date November 14, 2023
Est. primary completion date June 1, 2023
Accepts healthy volunteers No
Gender All
Age group 15 Years and older
Eligibility Inclusion Criteria: - Mothers in any trimester of pregnancy through 18 months postpartum who are enrolled in home visiting at a participating agency; - Fluent in English; - Mother and her family member have at least an 8th grade education; - Mothers with Beck Depression Inventory-Second Edition scores of at least 20; - Perceived Hostility Survey-Adult raw scores of at least 16 for the adult mother and her adult family member; Perceived Hostility Survey-Child raw scores of at least 14 for the adolescent mother and her adolescent intimate partner; and - Consistent internet access on their cell phones, tablets, or computer equipped with a microphone and camera. Exclusion Criteria: - Suicidal ideation in the mother and/or her family member; - Mothers with bipolar disorder symptoms; - Psychotic symptoms in the mother and/or her family member; - Mother is currently receiving individual therapy; - Family is currently receiving family therapy; - Mothers who have been taking an antidepressant for less than 2 months; and - Families with domestic violence.

Study Design


Intervention

Behavioral:
Resilience Enhancement Skills Training
Family therapy
Problem-Solving Individual Therapy
Individual therapy

Locations

Country Name City State
United States Dartmouth-Hitchcock Clinic Lebanon New Hampshire

Sponsors (2)

Lead Sponsor Collaborator
Dartmouth-Hitchcock Medical Center National Institute of Mental Health (NIMH)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Beck Depression Inventory-Second Edition Maternal depressive symptoms. The Beck Depression Inventory-Second Edition scores range from 0 (no depressive symptoms) to 63 (severe depressive symptoms). Change from baseline Beck Depression Inventory-Second Edition score at 6 months
Primary Perceived Hostility Survey (Ages 18 + and Ages 8-17) Family conflict. The Perceived Hostility Survey (Ages 18 +) raw scores range from 8 (low hostility) to 40 (high hostility). The Perceived Hostility Survey (Ages 8-17) raw scores range from 5 (low hostility) to 25 (high hostility). Change from baseline Perceived Hostility Survey score at 6 months
Primary Multidimensional Scale of Perceived Social Support - Family subscale Family cohesion. The Multidimensional Scale of Perceived Social Support-Family subscale scores range from 7-28, and higher scores indicate greater cohesion. Change from baseline Multidimensional Scale of Perceived Social Support-Family subscale score at 6 months
Primary Emotion Regulation Questionnaire-Cognitive Reappraisal scale (Adult version, and Children and Adolescents version) Family cognitive reappraisal. The Emotion Regulation Questionnaire-Cognitive Reappraisal scale (Adult version) scores range from 6 (infrequent use of cognitive reappraisal) to 42 (frequent use of cognitive reappraisal). The Emotion Regulation Questionnaire-Cognitive Reappraisal scale (Children and Adolescents version) scores range from 6 (infrequent use of cognitive reappraisal) to 30 (frequent use of cognitive reappraisal). Change from baseline Emotion Regulation Questionnaire-Cognitive Reappraisal scale score at 6 months
Secondary Maternal school enrollment/job attainment functional outcome Change from baseline maternal school enrollment/job attainment at 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT06348316 - Early Half Swaddling and Kangaroo Care Practices on Maternal Sleep Quality and Postpartum Depression in Term Babies N/A
Recruiting NCT05322161 - Yoga in the NICU for Parents Study N/A
Withdrawn NCT03709004 - Pacifiers and Breastfeeding Among Mothers at Risk for Postpartum Depression N/A
Completed NCT06305325 - Coparenting Intervention to Prevent Postpartum Depression N/A
Not yet recruiting NCT05055674 - The Effects of Motherly on Postpartum Depression N/A
Enrolling by invitation NCT02323152 - PREVENTION OF POSTPARTUM DEPRESSION DEVELOPMENT IN WOMEN WITH VERY HIGH RISK N/A
Not yet recruiting NCT01658098 - Prevalence of Postpartum Depression in Hospital Jose E. Gonzalez N/A
Completed NCT00961402 - The Effect of Exercise on Preventing PostPartum Depression Phase 2
Completed NCT01312883 - Mothers Avoiding Depression Through Empowerment Intervention Trial N/A
Completed NCT00360204 - Improving Health Outcomes for New Mothers and Babies Phase 3
Unknown status NCT00548743 - Translating Research Into Practice for Postpartum Depression N/A
Completed NCT04146025 - Nurtured in Nature N/A
Recruiting NCT05137925 - Mindful Moms: Mechanisms of Mindfulness-based Cognitive Therapy During Pregnancy and Postpartum N/A
Not yet recruiting NCT05299398 - Prevention of Postpartum Depression: A Pilot Placebo-controlled Trial of Trazodone Phase 1
Completed NCT04925765 - Virtual Reality Biofeedback for Postpartum Anxiety and Depression N/A
Recruiting NCT06053515 - Rosie the Chatbot: Leveraging Automated and Personalized Health Information Communication N/A
Completed NCT04037085 - Ketamine to Improve Recovery After Cesarean Delivery - Part 1 Phase 2
Completed NCT05059600 - A Study To Assess The Safe-Use Conditions For Administration of ZULRESSO® in a Home Setting Phase 4
Completed NCT06136520 - The Effect of Baby Massage Training Given to Pregnant Women on Maternal Attachment and Postpartum Depression N/A
Recruiting NCT05038085 - Postpartum Depression and Maternal Attachment N/A